CANDID-CNS™ Platform, a State-of-the-Art AI Model for Blood-Brain Barrier (BBB) Prediction of Small Molecules
Unlocking Beyond-Rule-of-5 (bRo5) Chemical Space and Stereochemistry for Small Molecule CNS Therapeutics
Access Application FormCANDID-CNS™ LoginRo5 Small Molecule
BBB Penetration Prediction
81%
CNS MPO
90%
AUPRC (CANDID-CNS™)
bRo5 Small Molecule
BBB Penetration Prediction
56%
CNS MPO
87%
AUPRC (CANDID-CNS™)
Stereoisomer Distinction
for Ro5 & bRo5 Penetration Prediction
50%
CNS MPO
68%
AUPRC (CANDID-CNS™)
Lead Optimization
Lead Triage & Ranking
CANDID™ Mode: Predictive AI
Lead Optimization
SAR Expansion
QM & CANDID™ Mode: Explainable AI
Chemist in a Loop Mode: Final Recommendations
Lead Optimization
When integrated with GenAI
BAGEL™ Mode: GenAI
Thank you.
Your request for PEGASUS™ 1.0 Platform access has been received.
Expect a reply within 1-3 business days.
Your request for PEGASUS™ 1.0 Platform access has been received.
Expect a reply within 1-3 business days.
Oops! Something went wrong while submitting the form.
